EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    2.7.1.4 | Acromegaly |
4042986 |
Disturbed prolactin responses to dopamine-related substances in patients with acromegaly and hyperprolactinemia. |
ongoing research
therapeutic application
unassigned |
3
1
0 |
| 2.7.1.4 | Acromegaly |
6810504 |
Plasma LH, FSH and TSH responses to the synthetic enkephalin analog (FK 33-824) in normal subjects and patients with pituitary diseases. |
causal interaction
diagnostic usage
unassigned |
4
2
0 |
| 2.7.1.4 | Acromegaly |
7462391 |
Plasma pituitary hormone responses to the synthetic enkephalin analog (FK 33-824) in normal subjects and patients with pituitary diseases. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
2
1 |
| 2.7.1.4 | Acute Kidney Injury |
16892534 |
[Pancreas transplant pathology: clinicopathologic and experimental findings] |
causal interaction
diagnostic usage
ongoing research
unassigned |
3
1
3
0 |
| 2.7.1.4 | Acute Kidney Injury |
28194018 |
Protective role of fructokinase blockade in the pathogenesis of acute kidney injury in mice. |
causal interaction
ongoing research
unassigned |
4
3
0 |
| 2.7.1.4 | Acute Kidney Injury |
28239174 |
Acute kidney injury: Benefits of blocking fructokinase. |
causal interaction
unassigned |
2
0 |
| 2.7.1.4 | Acute Kidney Injury |
28407885 |
The sweetest thing: blocking fructose metabolism to prevent acute kidney injury? |
causal interaction
therapeutic application
unassigned |
4
3
0 |
| 2.7.1.4 | Addison Disease |
3034555 |
Effects of ovine corticotropin-releasing hormone and FK 33-824 (met-enkephalin analogue) on the secretions of proopiomelanocortin-derived N-terminal peptide, beta-lipotropin, beta-endorphin and adrenocorticotropin in patients with Addison's disease. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
1
1
1 |
| 2.7.1.4 | Addison Disease |
6281297 |
Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
3
1
0 |
| 2.7.1.4 | Adenocarcinoma |
8517646 |
Clinical pharmacology of 11-acetyl-8-carbamoyloxymethyl-4-formyl-14-oxa-1,11-diazatetracyclo (7.4.1.0(2,7).0(10,12) tetradeca-2,4,6-trien-6,9-diyl diacetate (FK 973). |
ongoing research
unassigned |
4
0 |
